
Meera Natarajan
Examiner (ID: 11780, Phone: (571)270-3058 , Office: P/1643 )
| Most Active Art Unit | 1643 |
| Art Unit(s) | 1643 |
| Total Applications | 1062 |
| Issued Applications | 625 |
| Pending Applications | 87 |
| Abandoned Applications | 376 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5602249
[patent_doc_number] => 20060292594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'HDAC inhibitors that promote BRM expression and BRM related diagnostics'
[patent_app_type] => utility
[patent_app_number] => 11/365268
[patent_app_country] => US
[patent_app_date] => 2006-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19338
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20060292594.pdf
[firstpage_image] =>[orig_patent_app_number] => 11365268
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/365268 | Methods of identifying active BRM expression-promoting HDAC inhibitors | Feb 28, 2006 | Issued |
Array
(
[id] => 5619448
[patent_doc_number] => 20060188981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'MN gene and protein'
[patent_app_type] => utility
[patent_app_number] => 11/356568
[patent_app_country] => US
[patent_app_date] => 2006-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 32866
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20060188981.pdf
[firstpage_image] =>[orig_patent_app_number] => 11356568
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/356568 | MN gene and protein | Feb 16, 2006 | Issued |
Array
(
[id] => 7502883
[patent_doc_number] => 08034577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-11
[patent_title] => 'Methods and probes for detecting esophageal cancer'
[patent_app_type] => utility
[patent_app_number] => 11/356786
[patent_app_country] => US
[patent_app_date] => 2006-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 23866
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 229
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/034/08034577.pdf
[firstpage_image] =>[orig_patent_app_number] => 11356786
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/356786 | Methods and probes for detecting esophageal cancer | Feb 16, 2006 | Issued |
Array
(
[id] => 5689198
[patent_doc_number] => 20060287513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Compositions and methods for the therapy and diagnosis of breast cancer'
[patent_app_type] => utility
[patent_app_number] => 11/352424
[patent_app_country] => US
[patent_app_date] => 2006-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 47893
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20060287513.pdf
[firstpage_image] =>[orig_patent_app_number] => 11352424
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/352424 | Compositions and methods for the therapy and diagnosis of breast cancer | Feb 9, 2006 | Abandoned |
Array
(
[id] => 5602246
[patent_doc_number] => 20060292591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Genes from the 20q13 amplicon and their uses'
[patent_app_type] => utility
[patent_app_number] => 11/349066
[patent_app_country] => US
[patent_app_date] => 2006-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18643
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20060292591.pdf
[firstpage_image] =>[orig_patent_app_number] => 11349066
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/349066 | Genes from the 20q13 amplicon and their uses | Feb 5, 2006 | Issued |
Array
(
[id] => 4726698
[patent_doc_number] => 20080206239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Human Antibodies And Proteins'
[patent_app_type] => utility
[patent_app_number] => 11/815507
[patent_app_country] => US
[patent_app_date] => 2006-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 19164
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20080206239.pdf
[firstpage_image] =>[orig_patent_app_number] => 11815507
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/815507 | Human Antibodies And Proteins | Feb 2, 2006 | Abandoned |
Array
(
[id] => 133250
[patent_doc_number] => 07696320
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-13
[patent_title] => 'Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor'
[patent_app_type] => utility
[patent_app_number] => 11/331415
[patent_app_country] => US
[patent_app_date] => 2006-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 68
[patent_figures_cnt] => 68
[patent_no_of_words] => 59339
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/696/07696320.pdf
[firstpage_image] =>[orig_patent_app_number] => 11331415
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/331415 | Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor | Jan 10, 2006 | Issued |
Array
(
[id] => 177753
[patent_doc_number] => 07655461
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-02
[patent_title] => 'Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor associated antigen'
[patent_app_type] => utility
[patent_app_number] => 11/295767
[patent_app_country] => US
[patent_app_date] => 2005-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 17092
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/655/07655461.pdf
[firstpage_image] =>[orig_patent_app_number] => 11295767
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/295767 | Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor associated antigen | Dec 6, 2005 | Issued |
Array
(
[id] => 5843222
[patent_doc_number] => 20060121513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Nuclear targeting sequence'
[patent_app_type] => utility
[patent_app_number] => 11/293891
[patent_app_country] => US
[patent_app_date] => 2005-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7939
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20060121513.pdf
[firstpage_image] =>[orig_patent_app_number] => 11293891
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/293891 | Nuclear targeting sequence | Dec 1, 2005 | Issued |
Array
(
[id] => 4432585
[patent_doc_number] => 07968685
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-28
[patent_title] => 'Antibodies against Tenascin-C'
[patent_app_type] => utility
[patent_app_number] => 11/718919
[patent_app_country] => US
[patent_app_date] => 2005-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13263
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/968/07968685.pdf
[firstpage_image] =>[orig_patent_app_number] => 11718919
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/718919 | Antibodies against Tenascin-C | Oct 30, 2005 | Issued |
Array
(
[id] => 22772
[patent_doc_number] => 07794713
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-14
[patent_title] => 'Compositions and methods for the treatment and prevention of hyperproliferative diseases'
[patent_app_type] => utility
[patent_app_number] => 11/261935
[patent_app_country] => US
[patent_app_date] => 2005-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 21
[patent_no_of_words] => 18718
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/794/07794713.pdf
[firstpage_image] =>[orig_patent_app_number] => 11261935
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/261935 | Compositions and methods for the treatment and prevention of hyperproliferative diseases | Oct 27, 2005 | Issued |
Array
(
[id] => 5842249
[patent_doc_number] => 20060121042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Modulation of antibody specificity by tailoring the affinity to cognate antigens'
[patent_app_type] => utility
[patent_app_number] => 11/259133
[patent_app_country] => US
[patent_app_date] => 2005-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 63
[patent_figures_cnt] => 63
[patent_no_of_words] => 76824
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20060121042.pdf
[firstpage_image] =>[orig_patent_app_number] => 11259133
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/259133 | Modulation of antibody specificity by tailoring the affinity to cognate antigens | Oct 26, 2005 | Abandoned |
Array
(
[id] => 5040665
[patent_doc_number] => 20070092947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'Methods and compositions for increasing longevity and protein yield from a cell culture'
[patent_app_type] => utility
[patent_app_number] => 11/253666
[patent_app_country] => US
[patent_app_date] => 2005-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 14014
[patent_no_of_claims] => 103
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20070092947.pdf
[firstpage_image] =>[orig_patent_app_number] => 11253666
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/253666 | Methods and compositions for increasing longevity and protein yield from a cell culture | Oct 19, 2005 | Abandoned |
Array
(
[id] => 585367
[patent_doc_number] => 07446176
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-04
[patent_title] => '12 human secreted proteins'
[patent_app_type] => utility
[patent_app_number] => 11/246999
[patent_app_country] => US
[patent_app_date] => 2005-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 67
[patent_figures_cnt] => 67
[patent_no_of_words] => 290534
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/446/07446176.pdf
[firstpage_image] =>[orig_patent_app_number] => 11246999
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/246999 | 12 human secreted proteins | Oct 10, 2005 | Issued |
Array
(
[id] => 5865076
[patent_doc_number] => 20060099206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Methods and compositions for improving recombinant protein production'
[patent_app_type] => utility
[patent_app_number] => 11/244678
[patent_app_country] => US
[patent_app_date] => 2005-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15932
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20060099206.pdf
[firstpage_image] =>[orig_patent_app_number] => 11244678
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/244678 | Methods and compositions for improving recombinant protein production | Oct 4, 2005 | Issued |
Array
(
[id] => 5225578
[patent_doc_number] => 20070254845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-01
[patent_title] => 'Nucleophosmin/B23-binding peptide to inhibit tumor growth and regulate transcriptional activity of p53'
[patent_app_type] => utility
[patent_app_number] => 11/239032
[patent_app_country] => US
[patent_app_date] => 2005-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4816
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20070254845.pdf
[firstpage_image] =>[orig_patent_app_number] => 11239032
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/239032 | Nucleophosmin/B23-binding peptide to inhibit tumor growth and regulate transcriptional activity of p53 | Sep 29, 2005 | Issued |
Array
(
[id] => 5814027
[patent_doc_number] => 20060084124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Localization of A2B AdoR on human normal and diseased tissue: the use of anti-A2B antibody to diagnose and treat human tumors'
[patent_app_type] => utility
[patent_app_number] => 11/237086
[patent_app_country] => US
[patent_app_date] => 2005-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4865
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084124.pdf
[firstpage_image] =>[orig_patent_app_number] => 11237086
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/237086 | Localization of A2B AdoR on human normal and diseased tissue: the use of anti-A2B antibody to diagnose and treat human tumors | Sep 26, 2005 | Abandoned |
Array
(
[id] => 5040658
[patent_doc_number] => 20070092940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'Cysteine engineered antibodies and conjugates'
[patent_app_type] => utility
[patent_app_number] => 11/233258
[patent_app_country] => US
[patent_app_date] => 2005-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 47087
[patent_no_of_claims] => 126
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20070092940.pdf
[firstpage_image] =>[orig_patent_app_number] => 11233258
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/233258 | Cysteine engineered antibodies and conjugates | Sep 21, 2005 | Issued |
Array
(
[id] => 5742797
[patent_doc_number] => 20060088522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Humanized anti-5T4 antibodies and anti-5T4/calicheamicin conjugates'
[patent_app_type] => utility
[patent_app_number] => 11/221902
[patent_app_country] => US
[patent_app_date] => 2005-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 63
[patent_figures_cnt] => 63
[patent_no_of_words] => 31707
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20060088522.pdf
[firstpage_image] =>[orig_patent_app_number] => 11221902
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/221902 | Humanized anti-5T4 antibodies and anti-5T4/calicheamicin conjugates | Sep 8, 2005 | Abandoned |
Array
(
[id] => 590884
[patent_doc_number] => 07435806
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-10-14
[patent_title] => 'Nucleic acid binding of multi-zinc finger transcription factors'
[patent_app_type] => utility
[patent_app_number] => 11/196670
[patent_app_country] => US
[patent_app_date] => 2005-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22365
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/435/07435806.pdf
[firstpage_image] =>[orig_patent_app_number] => 11196670
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/196670 | Nucleic acid binding of multi-zinc finger transcription factors | Aug 2, 2005 | Issued |